IRAK1: a critical signaling mediator of innate immunity.

The innate immune system is equipped with sensitive and efficient machineries to provide an immediate, first line defense against infections. Toll-like receptors (TLRs) detect pathogens and the IL-1 receptor (IL-1R) family enables cells to quickly respond to inflammatory cytokines by mounting an efficient protective response. Interleukin-1 receptor activated kinases (IRAKs) are key mediators in the signaling pathways of TLRs/IL-1Rs. By means of their kinase and adaptor functions, IRAKs initiate a cascade of signaling events eventually leading to induction of inflammatory target gene expression. Due to this pivotal role, IRAK function is also highly regulated via multiple mechanisms. In this review, we focus on IRAK1, the earliest known and yet the most interesting member of this family. An overview on its structure, function and biology is given, with emphasis on the different novel mechanisms that regulate IRAK1 function. We also highlight several unresolved questions in this field and evaluate the potential of IRAK1 as a target for therapeutic intervention.

[1]  S. Wasserman,et al.  Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. , 1999, Journal of immunology.

[2]  Liwu Li,et al.  Regulation of IL-1 Receptor-Associated Kinases by Lipopolysaccharide1 , 2002, The Journal of Immunology.

[3]  T. Parsons,et al.  Regulation of IRAK-4 kinase activity via autophosphorylation within its activation loop. , 2007, Biochemical and biophysical research communications.

[4]  Liwu Li,et al.  IRAK1 Serves as a Novel Regulator Essential for Lipopolysaccharide-induced Interleukin-10 Gene Expression*♦ , 2004, Journal of Biological Chemistry.

[5]  J. Haas,et al.  Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers. , 1994, The Journal of biological chemistry.

[6]  K. Resch,et al.  The death domain of IRAK-1: an oligomerization domain mediating interactions with MyD88, Tollip, IRAK-1, and IRAK-4. , 2007, Biochemical and biophysical research communications.

[7]  Yingle Liu,et al.  The IRAK-1-BCL10-MALT1-TRAF6-TAK1 Cascade Mediates Signaling to NF-κB from Toll-like Receptor 4* , 2006, Journal of Biological Chemistry.

[8]  Crafford A. Harris,et al.  Interleukin (IL)-1 Receptor–associated Kinase (IRAK) Requirement for Optimal Induction of Multiple IL-1 Signaling Pathways and IL-6 Production , 1998, The Journal of experimental medicine.

[9]  J Fernando Bazan,et al.  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.

[10]  K. Torigoe,et al.  Purification and Characterization of the Human Interleukin-18 Receptor* , 1997, The Journal of Biological Chemistry.

[11]  S. Dower,et al.  Identification of Threonine 66 as a Functionally Critical Residue of the Interleukin-1 Receptor-associated Kinase* , 2002, The Journal of Biological Chemistry.

[12]  C. Coban,et al.  Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-α induction , 2005, The Journal of experimental medicine.

[13]  G. Sen,et al.  A critical role for IRAK4 kinase activity in Toll-like receptor–mediated innate immunity , 2007, The Journal of experimental medicine.

[14]  P. Preshaw,et al.  The expanding family of interleukin‐1 cytokines and their role in destructive inflammatory disorders , 2007, Clinical and experimental immunology.

[15]  M. Labow,et al.  The induction of EAE is only partially dependent on TNF receptor signaling but requires the IL-1 type I receptor. , 2000, Clinical immunology.

[16]  Sophie Janssens,et al.  Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. , 2003, Molecular cell.

[17]  J. Ninomiya-Tsuji,et al.  IRAK-mediated Translocation of TRAF6 and TAB2 in the Interleukin-1-induced Activation of NFκB* , 2001, The Journal of Biological Chemistry.

[18]  L. Ziegler‐Heitbrock,et al.  Tolerance Induced by the Lipopeptide Pam3Cys Is Due to Ablation of IL-1R-Associated Kinase-11 , 2004, The Journal of Immunology.

[19]  K. Irie,et al.  TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. , 2000, Molecular cell.

[20]  S. Akira,et al.  IL-18 Directs Autoreactive T Cells and Promotes Autodestruction in the Central Nervous System Via Induction of IFN-γ by NK Cells1 , 2000, The Journal of Immunology.

[21]  S. Morony,et al.  TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. , 1999, Genes & development.

[22]  S. Mizel,et al.  Gram-negative Flagellin-induced Self-tolerance Is Associated with a Block in Interleukin-1 Receptor-associated Kinase Release from Toll-like Receptor 5* , 2002, The Journal of Biological Chemistry.

[23]  Douglas K. Miller,et al.  The Interleukin-1 Receptor-associated Kinase Is Degraded by Proteasomes following Its Phosphorylation* , 1997, The Journal of Biological Chemistry.

[24]  Jae-Geun Yoon,et al.  CpG DNA Induces Self and Cross-Hyporesponsiveness of RAW264.7 Cells in Response to CpG DNA and Lipopolysaccharide: Alterations in IL-1 Receptor-Associated Kinase Expression1 , 2003, The Journal of Immunology.

[25]  Zhaodan Cao,et al.  TRAF6 is a signal transducer for interleukin-1 , 1996, Nature.

[26]  Z. Cao,et al.  IRAK: A Kinase Associated with the Interleukin-1 Receptor , 1996, Science.

[27]  F. Martinon,et al.  Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor , 2000, Nature Cell Biology.

[28]  M. Sweet,et al.  T1/ST2--an IL-1 receptor-like modulator of immune responses. , 2004, Cytokine & growth factor reviews.

[29]  C. McCall,et al.  Endotoxin-adapted septic shock leukocytes selectively alter production of sIL-1RA and IL-1beta. , 2001, Shock.

[30]  P. Feng,et al.  IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. , 1997, Science.

[31]  A. Whitehead,et al.  IRAK1b, a Novel Alternative Splice Variant of Interleukin-1 Receptor-associated Kinase (IRAK), Mediates Interleukin-1 Signaling and Has Prolonged Stability* , 2001, The Journal of Biological Chemistry.

[32]  Crafford A. Harris,et al.  Defective Interleukin (IL)-18–mediated Natural Killer and T Helper Cell Type 1 Responses in IL-1 Receptor–associated Kinase (IRAK)-deficient Mice , 1999, The Journal of experimental medicine.

[33]  Zhijian J. Chen,et al.  TAK1 is a ubiquitin-dependent kinase of MKK and IKK , 2001, Nature.

[34]  T. Born,et al.  Cloning of a Novel Receptor Subunit, AcPL, Required for Interleukin-18 Signaling* , 1998, The Journal of Biological Chemistry.

[35]  Q. Gu,et al.  Differential regulation of interleukin-1 receptor associated kinase 1 (IRAK1) splice variants. , 2007, Molecular immunology.

[36]  G. Stark,et al.  IRAK-M Is a Novel Member of the Pelle/Interleukin-1 Receptor-associated Kinase (IRAK) Family* , 1999, The Journal of Biological Chemistry.

[37]  K. Burns,et al.  Inhibition of Interleukin 1 Receptor/Toll-like Receptor Signaling through the Alternatively Spliced, Short Form of MyD88 Is Due to Its Failure to Recruit IRAK-4 , 2003, The Journal of experimental medicine.

[38]  J. Kirby,et al.  Toll-like receptor (TLR) response tolerance: a key physiological "damage limitation" effect and an important potential opportunity for therapy. , 2006, Current medicinal chemistry.

[39]  J. Casanova,et al.  IRAK4 Kinase Activity Is Redundant for Interleukin-1 (IL-1) Receptor-associated Kinase Phosphorylation and IL-1 Responsiveness* , 2004, Journal of Biological Chemistry.

[40]  G. Stark,et al.  Mutant Cells That Do Not Respond to Interleukin-1 (IL-1) Reveal a Novel Role for IL-1 Receptor-Associated Kinase , 1999, Molecular and Cellular Biology.

[41]  W. Fung-Leung,et al.  A Novel Splice Variant of Interleukin-1 Receptor (IL-1R)-Associated Kinase 1 Plays a Negative Regulatory Role in Toll/IL-1R-Induced Inflammatory Signaling , 2005, Molecular and Cellular Biology.

[42]  Thomas Hartung,et al.  Lipopolysaccharide- and Lipoteichoic Acid-Induced Tolerance and Cross-Tolerance: Distinct Alterations in IL-1 Receptor-Associated Kinase1 , 2002, The Journal of Immunology.

[43]  J. Knop,et al.  Effects of IL‐1 receptor‐associated kinase (IRAK) expression on IL‐1 signaling are independent of its kinase activity , 1999, FEBS letters.

[44]  K. Burns,et al.  Tollip Regulates Proinflammatory Responses to Interleukin-1 and Lipopolysaccharide , 2006, Molecular and Cellular Biology.

[45]  A. Kuglstatter,et al.  Cutting Edge: IL-1 Receptor-Associated Kinase 4 Structures Reveal Novel Features and Multiple Conformations , 2007, The Journal of Immunology.

[46]  R. Brigelius-Flohé,et al.  Cellular trafficking of the IL-1RI-associated kinase-1 requires intact kinase activity. , 2005, Biochemical and biophysical research communications.

[47]  Z. Cao,et al.  MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. , 1997, Immunity.

[48]  Liwu Li,et al.  Regulations and roles of the interleukin-1 receptor associated kinases (IRAKs) in innate and adaptive immunity , 2006, Immunologic research.

[49]  C. Radu,et al.  IL-1 Receptor-Associated Kinase 1 Regulates Susceptibility to Organ-Specific Autoimmunity1 , 2003, The Journal of Immunology.

[50]  Xiaoxia Li,et al.  Modulation of Toll–interleukin 1 receptor mediated signaling , 2005, Journal of Molecular Medicine.

[51]  Zhengfan Jiang,et al.  Interleukin-1 (IL-1) Receptor-Associated Kinase-Dependent IL-1-Induced Signaling Complexes Phosphorylate TAK1 and TAB2 at the Plasma Membrane and Activate TAK1 in the Cytosol , 2002, Molecular and Cellular Biology.

[52]  Zhengfan Jiang,et al.  Pellino 1 Is Required for Interleukin-1 (IL-1)-mediated Signaling through Its Interaction with the IL-1 Receptor-associated Kinase 4 (IRAK4)-IRAK-Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) Complex* , 2003, The Journal of Biological Chemistry.

[53]  M. Hayakawa,et al.  A novel splice variant of mouse interleukin-1-receptor-associated kinase-1 (IRAK-1) activates nuclear factor-kappaB (NF-kappaB) and c-Jun N-terminal kinase (JNK). , 2003, The Biochemical journal.

[54]  Zhijian J. Chen,et al.  Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin Chain , 2000, Cell.

[55]  Yingsu Huang,et al.  Novel role and regulation of the interleukin-1 receptor associated kinase (IRAK) family proteins. , 2005, Cellular & molecular immunology.

[56]  J. Cavaillon,et al.  Gamma Interferon and Granulocyte/Monocyte Colony-stimulating Factor Prevent Endotoxin Tolerance in Human Monocytes by Promoting Interleukin-1 Receptor-associated Kinase Expression and Its Association to MyD88 and Not by Modulating TLR4 Expression* , 2002, The Journal of Biological Chemistry.

[57]  M. J. Cody,et al.  Induction of In Vitro Reprogramming by Toll-Like Receptor (TLR)2 and TLR4 Agonists in Murine Macrophages: Effects of TLR “Homotolerance” Versus “Heterotolerance” on NF-κB Signaling Pathway Components1 , 2003, The Journal of Immunology.

[58]  S. Janssens,et al.  Pellino proteins are more than scaffold proteins in TLR/IL‐1R signalling: A role as novel RING E3–ubiquitin‐ligases , 2006, FEBS letters.

[59]  M. Hardy,et al.  The Murine Irak2 Gene Encodes Four Alternatively Spliced Isoforms, Two of Which Are Inhibitory* , 2004, Journal of Biological Chemistry.

[60]  H. Gram,et al.  IRAK-4 Kinase Activity Is Required for Interleukin-1 (IL-1) Receptor- and Toll-like Receptor 7-mediated Signaling and Gene Expression* , 2007, Journal of Biological Chemistry.

[61]  Sankar Ghosh,et al.  Negative Regulation of Toll-like Receptor-mediated Signaling by Tollip* , 2002, The Journal of Biological Chemistry.

[62]  A. Sher,et al.  Cooperation of Toll-like receptor signals in innate immune defence , 2007, Nature Reviews Immunology.

[63]  C. Janeway,et al.  ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. , 1999, Genes & development.

[64]  R. Brigelius-Flohé,et al.  Translocation of the interleukin‐1 receptor‐associated kinase‐1 (IRAK‐1) into the nucleus , 2000, FEBS letters.

[65]  S. Akira,et al.  Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor–mediated immune responses but not in TCR signaling , 2007, The Journal of experimental medicine.

[66]  Liwu Li,et al.  Characterization of Interleukin-1 Receptor-associated Kinase in Normal and Endotoxin-tolerant Cells* , 2000, The Journal of Biological Chemistry.

[67]  J. Swantek,et al.  IL-1 Receptor-Associated Kinase Modulates Host Responsiveness to Endotoxin1 , 2000, The Journal of Immunology.